Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,772 total articles

Devon Energy and Coterra Energy Complete Merger

Devon Energy and Coterra Energy Complete Merger

Devon Energy Corporation and Coterra Energy Inc. have completed an all-stock merger, creating a leading U.S. shale producer with a strong asset base, particularly in the Delaware Basin. The combined company will retain the Devon Energy name and ticker (DVN) and is targeting $1 billion in annual cost synergies by the end of 2027. The merger position…

Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership

Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership

Prenetics Global Limited, trading as PRE on NASDAQ, announced a multi-year exclusive partnership between its premium health brand IM8 and Major League Soccer club Inter Miami CF. The deal includes IM8 becoming the exclusive official health supplements partner of the club, placement of IM8 products in the team's daily routines, branding opportunitie…

SS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress

SS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress

SS Innovations International, Inc. announced the successful completion of a long-distance telesurgery spanning more than 4,500 miles, using their proprietary SSi Mantra surgical robotic system and the portable SSi MantrAsana tele-surgeon console. The procedure was performed remotely from Australia to India during the Royal Australian College of Sur…

Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation

Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation

Oragenics, Inc. announced a Letter of Intent to license CardioDialysis™ technology from Sigyn Therapeutics to develop treatments for traumatic brain injury (TBI) and related neurodegenerative diseases. This technology complements Oragenics' ongoing Phase IIa trial of ONP-002 by targeting systemic inflammation outside the brain, potentially creating…

Drone Makers ACSL and Draganfly Partner to Bring NDAA-Compliant Japanese Drones to Canadian Market; Signs Exclusive Distributor Agreement and Launches Technology Integration

Drone Makers ACSL and Draganfly Partner to Bring NDAA-Compliant Japanese Drones to Canadian Market; Signs Exclusive Distributor Agreement and Launches Technology Integration

Draganfly Inc. has signed an exclusive master distributor agreement with ACSL, the largest Japanese drone maker, to introduce ACSL's NDAA-compliant SOTEN drone platform to the Canadian market. This collaboration enables cross-platform interoperability, allowing drones from both companies to share payloads and control systems, expanding capabilities…

MARA Announces Launch of Consent Solicitation for the 8.750% Senior Secured Notes due 2032 of Long Ridge Energy LLC

MARA Announces Launch of Consent Solicitation for the 8.750% Senior Secured Notes due 2032 of Long Ridge Energy LLC

MARA Holdings, Inc. announced a consent solicitation to amend the indenture governing Long Ridge Energy LLC's 8.750% Senior Secured Notes due 2032. This is part of MARA's planned acquisition of Long Ridge Energy & Power LLC, aiming to avoid a change of control event under the note indenture. The solicitation seeks bondholders' consent to amend term…

Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

Milestone Scientific (NYSE: MLSS) announced progress on expanding its CompuFlo® medical business, including growth of an Advisor Program driving physician utilization, regional expansion into Medicare and commercial payer jurisdictions, and partnerships with academic institutions for clinical validation. The company is building out its sales presen…

Innventure to Announce First Quarter 2026 Results on May 14, 2026

Innventure to Announce First Quarter 2026 Results on May 14, 2026

Innventure, Inc., an industrial growth conglomerate focused on commercializing breakthrough technologies, announced it will release its first quarter 2026 financial results after market close on May 14, 2026. The company will host a conference call to discuss the results, which will be webcast live and available for replay on its investor relations…

AIM ImmunoTech Announces 50% Objective Response Rate (ORR) in UPMC Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential

AIM ImmunoTech Announces 50% Objective Response Rate (ORR) in UPMC Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential

AIM ImmunoTech announced a 50% Objective Response Rate in a Phase 2 clinical trial conducted by UPMC, testing their drug Ampligen in combination with checkpoint inhibitors and chemotherapy for recurrent ovarian cancer. The trial showed durable responses, clinical benefit, and no severe toxicities, indicating Ampligen's potential to enhance immunoth…

Inuvo to Host First Quarter 2026 Financial Results Conference Call on Thursday, May 14th at 4:15 P.M. ET

Inuvo to Host First Quarter 2026 Financial Results Conference Call on Thursday, May 14th at 4:15 P.M. ET

Inuvo, Inc., an AI-driven advertising technology company, announced it will hold a conference call on May 14, 2026, to discuss its financial results for the first quarter ended March 31, 2026, and provide a business update. The call details and replay information were provided, highlighting Inuvo's patented IntentKey AI technology for media audienc…

Regency Centers Declares Quarterly Dividends

Regency Centers Declares Quarterly Dividends

Regency Centers Corporation declared quarterly cash dividends for its common stock as well as Series A and Series B preferred stocks. The common stock dividend of $0.755 per share will be paid on July 2, 2026, and dividends for preferred stocks will be paid on July 31, 2026. Regency Centers is a leading national real estate investment trust focusin…

VCI Global Enters Binding Term Sheet for Strategic Investment in Brazil Gold Asset, Advancing Integration of Physical Gold into RWA and Digital Asset Treasury Strategy

VCI Global Enters Binding Term Sheet for Strategic Investment in Brazil Gold Asset, Advancing Integration of Physical Gold into RWA and Digital Asset Treasury Strategy

VCI Global Limited has entered a binding term sheet to make a strategic investment in a gold mining asset in Brazil with estimated gold resources of approximately 59.9 tonnes. The company plans to initially invest and act as EPC partner, retaining an option to increase ownership to 51%. This aligns with VCI Global's strategy to integrate physical c…

ENvue Medical Secures Three-Year Purchasing Agreement Renewal with the Group Purchasing Organization (GPO) for One of the Largest Health Systems in the U.S. Operating Over 90 Hospitals

ENvue Medical Secures Three-Year Purchasing Agreement Renewal with the Group Purchasing Organization (GPO) for One of the Largest Health Systems in the U.S. Operating Over 90 Hospitals

ENvue Medical has secured a three-year renewal of its purchasing agreement with a Group Purchasing Organization representing one of the largest non-profit health systems in the United States, which operates more than 90 hospitals. This renewal guarantees hospitals within the network continued access to ENvue's Navigation Platform, facilitating easi…

Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline

Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline

Scienture Holdings, Inc. has secured $11 million in non-dilutive debt financing through promissory notes to support the commercialization of its FDA-approved products, Arbli™ for hypertension and REZENOPY™ for opioid overdose treatment, as well as to advance its diverse R&D pipeline. The financing aims to strengthen Scienture's capital position and…

Alpha Modus and SurgePays Sign 25,000-Activation Pilot to Launch Alpha Cash Across SurgePays' Prepaid Wireless and Convenience-Store Distribution Network

Alpha Modus and SurgePays Sign 25,000-Activation Pilot to Launch Alpha Cash Across SurgePays' Prepaid Wireless and Convenience-Store Distribution Network

Alpha Modus Holdings and SurgePays announced a multi-year commercial agreement to integrate and distribute the Alpha Cash mobile wallet through SurgePays' prepaid wireless and convenience-store channels. The partnership targets the large underbanked U.S. consumer market by embedding the wallet within existing onboarding and retail platforms, commen…

Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury

Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury

Silo Pharma announced a strategic initiative exploring ibogaine-based therapeutics for traumatic brain injury (TBI) and related neuropsychiatric disorders, filing a provisional patent for compositions using ibogaine. This effort aligns with recent FDA breakthroughs and reflects promising clinical data showing symptom reduction and brain structural …

Inseego Names Koroush Saraf Chief Product Officer to Drive Innovation and Next Phase of Product Strategy

Inseego Names Koroush Saraf Chief Product Officer to Drive Innovation and Next Phase of Product Strategy

Inseego Corp. has appointed Koroush Saraf as Chief Product Officer to spearhead product strategy and growth amid expanding scale and capabilities, including after the acquisition of Nokia's Fixed Wireless Access business. Saraf brings extensive experience in SD-WAN, cloud security, LTE, 5G, and edge AI infrastructure, aligning with Inseego's focus …

Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings

Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings

Ardelyx, Inc. announced positive long-term safety data of its FDA-approved drug XPHOZAH (tenapanor) for managing serum phosphorus in chronic kidney disease patients on dialysis. Data from two clinical trials reflect no significant changes in serum electrolytes other than phosphate, nutritional markers, body mass, or blood pressure, reinforcing the …

Micropolis Robotics Expands Industrial Automation Footprint with USD $1.2 Million EMSTEEL Agreement

Micropolis Robotics Expands Industrial Automation Footprint with USD $1.2 Million EMSTEEL Agreement

Micropolis AI Robotics, a UAE-based autonomous robotics developer, announced a $1.2 million agreement with EMSTEEL to deploy four M01 autonomous logistics robots in industrial environments. This phased project includes validation, application development, certification, and full deployment to enhance automation and operational efficiency in steel m…